Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Pediatric individuals seen in the Pediatric Immunodeficiency clinic for evaluation of primary immunodeficiencies (PIDs).
- Patients with a confirmed diagnosis of PIDs
- Pediatric individuals who are confirmed as not having a primary immunodeficiency or any immunological anomaly will be consented as a healthy participant for inclusion in the Reference Range Sample Bank.